{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:46:16Z","timestamp":1785509176103,"version":"3.56.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,28]]},"DOI":"10.7759\/cureus.72589","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T04:15:27Z","timestamp":1730175327000},"source":"Crossref","is-referenced-by-count":1,"title":["The Unusual Clinical Presentation of Eosinophilic Gastroenteritis and Its Response to Mepolizumab: Two Case Reports"],"prefix":"10.7759","author":[{"given":"Mahmoud A","family":"Kiblawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazin M","family":"Edan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/CEG.S173130","article-title":"Eosinophilic gastroenteritis: diagnosis and clinical perspectives","volume":"12","author":"Sunkara T","year":"2019","unstructured":"Sunkara T, Rawla P, Yarlagadda KS, Gaduputi V. Eosinophilic gastroenteritis: diagnosis and clinical perspectives. Clin Exp Gastroenterol. 2019, 12:239-53. 10.2147\/CEG.S173130","journal-title":"Clin Exp Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4292\/wjgpt.v7.i4.513","article-title":"Eosinophilic gastroenteritis: approach to diagnosis and management","volume":"7","author":"Rached AA","year":"2016","unstructured":"Rached AA, El Hajj W. Eosinophilic gastroenteritis: approach to diagnosis and management. World J Gastrointest Pharmacol Ther. 2016, 7:513-23. 10.4292\/wjgpt.v7.i4.513","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"ref3","article-title":"Eosinophilic Gastroenteritis","author":"Memon RJ","year":"2024","unstructured":"Memon RJ, Savliwala MN. Eosinophilic Gastroenteritis. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000002511","article-title":"Eosinophilic gastroenteritis: pathogenesis, diagnosis, and treatment","volume":"136","author":"Li K","year":"2023","unstructured":"Li K, Ruan G, Liu S, Xu T, Guan K, Li J, Li J. Eosinophilic gastroenteritis: pathogenesis, diagnosis, and treatment. Chin Med J (Engl). 2023, 136:899-909. 10.1097\/CM9.0000000000002511","journal-title":"Chin Med J (Engl)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/0300060520917274","article-title":"Eosinophilic gastroenteritis with multiple serous membrane effusion as the first sign: a case report and literature review","volume":"48","author":"Liang M","year":"2020","unstructured":"Liang M, Liwen Z, Bingfang C, Yanbo D, Jianping C. Eosinophilic gastroenteritis with multiple serous membrane effusion as the first sign: a case report and literature review. J Int Med Res. 2020, 48:300060520917274. 10.1177\/0300060520917274","journal-title":"J Int Med Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v6.i7.156","article-title":"Massive hemorrhagic ascites: a rare presentation of eosinophilic gastroenteritis","volume":"6","author":"Shi L","year":"2018","unstructured":"Shi L, Jia QH, Liu FJ, Guan H, Jiang ZY. Massive hemorrhagic ascites: a rare presentation of eosinophilic gastroenteritis. World J Clin Cases. 2018, 6:156-60. 10.12998\/wjcc.v6.i7.156","journal-title":"World J Clin Cases"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-021-00809-2","article-title":"Eosinophilic gastritis\/gastroenteritis","volume":"23","author":"Chen PH","year":"2021","unstructured":"Chen PH, Anderson L, Zhang K, Weiss GA. Eosinophilic gastritis\/gastroenteritis. Curr Gastroenterol Rep. 2021, 23:13. 10.1007\/s11894-021-00809-2","journal-title":"Curr Gastroenterol Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2022.06.015","article-title":"Biologics in eosinophilic gastrointestinal diseases","volume":"130","author":"Dellon ES","year":"2023","unstructured":"Dellon ES, Spergel JM. Biologics in eosinophilic gastrointestinal diseases. Ann Allergy Asthma Immunol. 2023, 130:21-7. 10.1016\/j.anai.2022.06.015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref9","article-title":"Nucala (mepolizumab): first IL-5 antagonist monoclonal antibody FDA approved for maintenance treatment of patients with severe asthma","volume":"9","author":"Fala L","year":"2016","unstructured":"Fala L. Nucala (mepolizumab): first IL-5 antagonist monoclonal antibody FDA approved for maintenance treatment of patients with severe asthma. Am Health Drug Benefits. 2016, 9:106-10.","journal-title":"Am Health Drug Benefits"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastha.2022.03.003","article-title":"A case of eosinophilic gastroenteritis remission achieved steroid-free with mepolizumab","volume":"1","author":"Hirata Y","year":"2022","unstructured":"Hirata Y, Nakamura T, Higuchi K. A case of eosinophilic gastroenteritis remission achieved steroid-free with mepolizumab. Gastro Hep Adv. 2022, 1:553-4. 10.1016\/j.gastha.2022.03.003","journal-title":"Gastro Hep Adv"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1745834","article-title":"Eosinophilic gastroenteritis with a relapsing and remitting course with presence of autoimmune antibodies","volume":"2020","author":"Fonseka CL","year":"2020","unstructured":"Fonseka CL, Nanayakkara S, Singhapura SD, Herath HM, Bodinayake CK. Eosinophilic gastroenteritis with a relapsing and remitting course with presence of autoimmune antibodies. Case Rep Med. 2020, 2020:1745834. 10.1155\/2020\/1745834","journal-title":"Case Rep Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/275275-the-unusual-clinical-presentation-of-eosinophilic-gastroenteritis-and-its-response-to-mepolizumab-two-case-reports","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T04:15:30Z","timestamp":1730175330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/275275-the-unusual-clinical-presentation-of-eosinophilic-gastroenteritis-and-its-response-to-mepolizumab-two-case-reports"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.72589","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,28]]}}}